Skip to content

MBX Biosciences, Inc. MBX Balance Sheet Statement

FY'25FY'24FY'23
$75.29M+52.6%$49.35M+61.7%$30.52M
$298.42M+40.2%$212.8M+324%$50.15M
$381.54M+42.7%$267.29M+220%$83.47M
$2.74M+153%$1.08M+146%$439K
$385.14M+43.4%$268.54M+219%$84.18M
$16.75M+47.1%$11.39M+570%$1.7M
$15.5M+40.2%$11.05M+181%$3.93M
$15.92M+43.5%$11.09M+159%$4.29M
$6K+20.0%$5K+400%$1K
-$224.48M-63.2%-$137.51M-81.9%-$75.58M
$369.22M+43.4%$257.44M+455%-$72.47M-70.1%
$385.14M+43.4%$268.54M+219%$84.18M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are MBX Biosciences, Inc.'s total assets?
MBX Biosciences, Inc. (MBX) holds $452.7M in total assets, up 84.1% year over year.
How much debt does MBX Biosciences, Inc. have?
MBX Biosciences, Inc. carries $555.0K in total debt against $437.8M of shareholders' equity, a debt-to-equity ratio of 0.00.
How much cash does MBX Biosciences, Inc. have?
MBX Biosciences, Inc. holds $45.2M in cash and equivalents.
Can MBX Biosciences, Inc. cover its short-term obligations?
Its current ratio is 30.79 — current assets exceed current liabilities.
Where does MBX Biosciences, Inc.'s balance sheet data come from?
Every line is extracted from MBX Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.